Stem cell therapy for chronic heart failure: An updated appraisal

Simon Maltais, Steven J. Joggerst, Antonis Hatzopoulos, Thomas G. Disalvo, David Zhao, Hak Joon Sung, Xintong Wang, John G. Byrne, Allen J. Naftilan

Research output: Contribution to journalReview article

9 Citations (Scopus)

Abstract

Introduction: Significant advances have been made to understand the mechanisms involved in cardiac cell-based therapies. The early translational application of basic science knowledge has led to several animal and human clinical trials. The initial promising beneficial effect of stem cells on cardiac function restoration has been eclipsed by the inability of animal studies to translate into sustained clinical improvements in human clinical trials. Areas covered: In this review, the authors cover an updated overview of various stem cell populations used in chronic heart failure. A critical review of clinical trials conducted in advanced heart failure patients is proposed, and finally promising avenues for developments in the field of cardiac cell-based therapies are presented. Expert opinion: Several questions remain unanswered, and this limits our ability to understand basic mechanisms involved in stem cell therapeutics. Human studies have revealed critical unresolved issues. Further elucidation of the proper timing, mode delivery and prosurvival factors is imperative, if the field is to advance. The limited benefits seen to date are simply not enough if the potential for substantial recovery of nonfunctioning myocardium is to be realized.

Original languageEnglish (US)
Pages (from-to)503-516
Number of pages14
JournalExpert Opinion on Biological Therapy
Volume13
Issue number4
DOIs
StatePublished - Jan 1 2013
Externally publishedYes

Fingerprint

Cell- and Tissue-Based Therapy
Stem cells
Stem Cells
Heart Failure
Clinical Trials
Animals
Expert Testimony
Restoration
Myocardium
Recovery
Population
Therapeutics

Keywords

  • Cell sources
  • Cell-based therapy
  • Heart failure
  • Stem cells

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery
  • Clinical Biochemistry

Cite this

Maltais, S., Joggerst, S. J., Hatzopoulos, A., Disalvo, T. G., Zhao, D., Sung, H. J., ... Naftilan, A. J. (2013). Stem cell therapy for chronic heart failure: An updated appraisal. Expert Opinion on Biological Therapy, 13(4), 503-516. https://doi.org/10.1517/14712598.2013.749852

Stem cell therapy for chronic heart failure : An updated appraisal. / Maltais, Simon; Joggerst, Steven J.; Hatzopoulos, Antonis; Disalvo, Thomas G.; Zhao, David; Sung, Hak Joon; Wang, Xintong; Byrne, John G.; Naftilan, Allen J.

In: Expert Opinion on Biological Therapy, Vol. 13, No. 4, 01.01.2013, p. 503-516.

Research output: Contribution to journalReview article

Maltais, S, Joggerst, SJ, Hatzopoulos, A, Disalvo, TG, Zhao, D, Sung, HJ, Wang, X, Byrne, JG & Naftilan, AJ 2013, 'Stem cell therapy for chronic heart failure: An updated appraisal', Expert Opinion on Biological Therapy, vol. 13, no. 4, pp. 503-516. https://doi.org/10.1517/14712598.2013.749852
Maltais, Simon ; Joggerst, Steven J. ; Hatzopoulos, Antonis ; Disalvo, Thomas G. ; Zhao, David ; Sung, Hak Joon ; Wang, Xintong ; Byrne, John G. ; Naftilan, Allen J. / Stem cell therapy for chronic heart failure : An updated appraisal. In: Expert Opinion on Biological Therapy. 2013 ; Vol. 13, No. 4. pp. 503-516.
@article{76f9393a6c374f7096118efd0bf93a64,
title = "Stem cell therapy for chronic heart failure: An updated appraisal",
abstract = "Introduction: Significant advances have been made to understand the mechanisms involved in cardiac cell-based therapies. The early translational application of basic science knowledge has led to several animal and human clinical trials. The initial promising beneficial effect of stem cells on cardiac function restoration has been eclipsed by the inability of animal studies to translate into sustained clinical improvements in human clinical trials. Areas covered: In this review, the authors cover an updated overview of various stem cell populations used in chronic heart failure. A critical review of clinical trials conducted in advanced heart failure patients is proposed, and finally promising avenues for developments in the field of cardiac cell-based therapies are presented. Expert opinion: Several questions remain unanswered, and this limits our ability to understand basic mechanisms involved in stem cell therapeutics. Human studies have revealed critical unresolved issues. Further elucidation of the proper timing, mode delivery and prosurvival factors is imperative, if the field is to advance. The limited benefits seen to date are simply not enough if the potential for substantial recovery of nonfunctioning myocardium is to be realized.",
keywords = "Cell sources, Cell-based therapy, Heart failure, Stem cells",
author = "Simon Maltais and Joggerst, {Steven J.} and Antonis Hatzopoulos and Disalvo, {Thomas G.} and David Zhao and Sung, {Hak Joon} and Xintong Wang and Byrne, {John G.} and Naftilan, {Allen J.}",
year = "2013",
month = "1",
day = "1",
doi = "10.1517/14712598.2013.749852",
language = "English (US)",
volume = "13",
pages = "503--516",
journal = "Expert Opinion on Biological Therapy",
issn = "1471-2598",
publisher = "Informa Healthcare",
number = "4",

}

TY - JOUR

T1 - Stem cell therapy for chronic heart failure

T2 - An updated appraisal

AU - Maltais, Simon

AU - Joggerst, Steven J.

AU - Hatzopoulos, Antonis

AU - Disalvo, Thomas G.

AU - Zhao, David

AU - Sung, Hak Joon

AU - Wang, Xintong

AU - Byrne, John G.

AU - Naftilan, Allen J.

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Introduction: Significant advances have been made to understand the mechanisms involved in cardiac cell-based therapies. The early translational application of basic science knowledge has led to several animal and human clinical trials. The initial promising beneficial effect of stem cells on cardiac function restoration has been eclipsed by the inability of animal studies to translate into sustained clinical improvements in human clinical trials. Areas covered: In this review, the authors cover an updated overview of various stem cell populations used in chronic heart failure. A critical review of clinical trials conducted in advanced heart failure patients is proposed, and finally promising avenues for developments in the field of cardiac cell-based therapies are presented. Expert opinion: Several questions remain unanswered, and this limits our ability to understand basic mechanisms involved in stem cell therapeutics. Human studies have revealed critical unresolved issues. Further elucidation of the proper timing, mode delivery and prosurvival factors is imperative, if the field is to advance. The limited benefits seen to date are simply not enough if the potential for substantial recovery of nonfunctioning myocardium is to be realized.

AB - Introduction: Significant advances have been made to understand the mechanisms involved in cardiac cell-based therapies. The early translational application of basic science knowledge has led to several animal and human clinical trials. The initial promising beneficial effect of stem cells on cardiac function restoration has been eclipsed by the inability of animal studies to translate into sustained clinical improvements in human clinical trials. Areas covered: In this review, the authors cover an updated overview of various stem cell populations used in chronic heart failure. A critical review of clinical trials conducted in advanced heart failure patients is proposed, and finally promising avenues for developments in the field of cardiac cell-based therapies are presented. Expert opinion: Several questions remain unanswered, and this limits our ability to understand basic mechanisms involved in stem cell therapeutics. Human studies have revealed critical unresolved issues. Further elucidation of the proper timing, mode delivery and prosurvival factors is imperative, if the field is to advance. The limited benefits seen to date are simply not enough if the potential for substantial recovery of nonfunctioning myocardium is to be realized.

KW - Cell sources

KW - Cell-based therapy

KW - Heart failure

KW - Stem cells

UR - http://www.scopus.com/inward/record.url?scp=84879567763&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879567763&partnerID=8YFLogxK

U2 - 10.1517/14712598.2013.749852

DO - 10.1517/14712598.2013.749852

M3 - Review article

C2 - 23289619

AN - SCOPUS:84879567763

VL - 13

SP - 503

EP - 516

JO - Expert Opinion on Biological Therapy

JF - Expert Opinion on Biological Therapy

SN - 1471-2598

IS - 4

ER -